Category

Global Clinical Trial Management System (CTMS) Market - Forecasts From 2019 To 2024

90 pages
Published on : May 2019
Report Code : KSI061612086

Description

The global clinical trial management system (CTMS) market is expected to reach US$1,704.371 million by 2024 from US$948.962 million in 2018 growing at a CAGR of 10.25%. Clinical trial management system (CTMS) is a web based technology solution that centralizes the management aspect of clinical trials resulting in streamline business processes, enhanced efficiency, reduced administrative work and reduced time and cost of clinical trials. Key application area for CTMS include protocol development, data analysis and reporting, collection, monitoring and processing of data, site selection and trial preparation etc. The Clinical Trial Management System (CTMS) market is anticipated to show significant growth during the forecast period rising number of drug development and clinical research activities. Growing trend towards integrating Hospital Information System (HIS) with CTMS will also augment the growth of the market. Rising demand of the CTMS to reduce the cost and administrative burden of the clinical will also boost the adoption of CTMS, thus, having a positive impact on the market. However, issues related to the data security coupled with the high cost of CTMS might hinder the growth of the market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Clinical Trial Management System (CTMS) market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Clinical Trial Management System (CTMS) market.

Major industry players profiled as part of the report are Oracle, Ennov and Breeze CTMS among others.

Segmentation

By Type

Enterprise CTMS

Site CTMS

 

By Deployment Model

Cloud Based CTMS

On Premise CTMS

 

By Component

Services

Software

 

By End Users

Pharmaceutical and Biopharmaceutical Companies

Other Healthcare Providers

CROs

 

By Geography

North America

United States

Canada

Others

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Others

 

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

 

Asia Pacific

China

India

Australia

South Korea

Others

OUR CLIENTS